Adrenaline (epinephrine) auto-injector for the treatment of anaphylaxis with and without cardiovascular collapse in the community
Evidence Summaries
There are no randomized controlled trials 1 of adrenaline auto-injectors in the treatment of anaphylaxis. While adrenaline is the drug of choice for anaphylaxis, trials are unlikely to be performed because of ethical concerns associated with randomization to placebo. Several observational studies and case series show a better prognosis for patients who receive adrenaline early compared to those who receive delayed adrenaline.
References
Copyright © 2023 Duodecim Medical Publications Limited.
To view other topics, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Complete Product Information.